Access cutting-edge prader-willi syndrome treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access prader-willi syndrome specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prader-willi syndrome treatment provided free
This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, global clinical study to assess the efficacy and safety of pitolisant in patients living with Prader-Willi syndrome. The primary objective of this study is to evaluate the efficacy of pitolisant in treating excessive daytime sleepiness (EDS) in patients ≥6 years of age with Prader-Willi syndrome. Secondary objectives include assessing the impact of pitolisant on: Irritable and disruptive behaviors Hyperphagia Other
Sponsor: Harmony Biosciences Management, Inc.
Check if you qualify for this prader-willi syndrome clinical trial in Atlanta, GA
If you're searching for prader-willi syndrome treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prader-willi syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.